These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3414230)
1. [A new approach to selecting antibacterial preparations for treating patients with chronic urological infections]. Korshunov VM; Nizamov FZ; Ivanova NP; Ukhin AV; Zakhmatov IuM Zh Mikrobiol Epidemiol Immunobiol; 1988 Apr; (4):8-13. PubMed ID: 3414230 [TBL] [Abstract][Full Text] [Related]
2. [Sensitivity of the intestinal microflora of patients to antimicrobial preparations studied in order to conduct rational antibiotic treatment]. Korshunov VM; Sinitsyna NA; Levashev VS; Ginodman GA Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):24-30. PubMed ID: 3716687 [TBL] [Abstract][Full Text] [Related]
3. [A rapid test of urine microflora sensitivity to antibacterial drugs in the treatment of children with nonspecific inflammatory diseases of the kidney and urinary tract]. Rodoman VE; Laberko LA; Korotaev AL; Zarma AA Pediatriia; 1989; (6):57-61. PubMed ID: 2762056 [TBL] [Abstract][Full Text] [Related]
4. Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections. Edlund C; Nord CE J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():41-8; discussion 63-5. PubMed ID: 11051623 [TBL] [Abstract][Full Text] [Related]
5. Impact of Clinical and Laboratory Standards Institute breakpoint changes on susceptibility rates of cephalosporins in uncomplicated urinary tract infections caused by Enterobacteriaceae. Bunnell KL; Wenzler E; Harrington AT; Danziger LH Diagn Microbiol Infect Dis; 2018 Apr; 90(4):335-336. PubMed ID: 29395714 [TBL] [Abstract][Full Text] [Related]
6. Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae. Raja NS J Infect Public Health; 2019; 12(6):843-846. PubMed ID: 31176606 [TBL] [Abstract][Full Text] [Related]
8. Interaction between Antibiotic Resistance, Resistance Genes, and Treatment Response for Urinary Tract Infections in Primary Care. Ho HJ; Tan MX; Chen MI; Tan TY; Koo SH; Koong AYL; Ng LP; Hu PL; Tan KT; Moey PKS; Koh EYL; Wong CS; Lye DC; Tan NC J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31243084 [TBL] [Abstract][Full Text] [Related]
9. A case of Raoultella ornithinolytica urinary tract infection in a pediatric patient. Büyükcam A; Liste Ü; Bıçakçıgil A; Kara A; Sancak B J Infect Chemother; 2019 Jun; 25(6):467-469. PubMed ID: 30683499 [TBL] [Abstract][Full Text] [Related]
10. Switching from CLSI to EUCAST XL susceptibility breakpoint: its implication in urinary tract infection in men. Aguirre-Quiñonero A; Lecaroz Agara MC; Canut Blasco A Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1813-1815. PubMed ID: 29936620 [No Abstract] [Full Text] [Related]
12. [Effectiveness of using aminoglycoside antibiotics in septicemia and urinary tract infections in newborn infants]. Sentsova TB; Bombardirova EP; Mamedkulieva DT; Bekmukhambetova ER Antibiot Khimioter; 1990 Oct; 35(10):50-2. PubMed ID: 2126174 [TBL] [Abstract][Full Text] [Related]
13. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years. Aris P; Boroumand MA; Rahbar M; Douraghi M Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348 [TBL] [Abstract][Full Text] [Related]
14. Recurrent urinary tract infections caused by Raoultella planticola after kidney transplant. Harmon SL; Nadeem I Transpl Infect Dis; 2019 Dec; 21(6):e13196. PubMed ID: 31610079 [TBL] [Abstract][Full Text] [Related]
15. [Infectious drug resistance factors in Enterobacteriaceae producing urinary tract infections]. Lachmajer M; Bugalski R Med Dosw Mikrobiol; 1972; 24(2):95-101. PubMed ID: 5035828 [No Abstract] [Full Text] [Related]
16. Relationship of infecting urinary organism to the faecal flora in patients with symptomatic urinary infection. Grüneberg RN Lancet; 1969 Oct; 2(7624):766-8. PubMed ID: 4186020 [No Abstract] [Full Text] [Related]
17. In vitro activity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections. Stone GG; Bradford PA; Yates K; Newell P J Antimicrob Chemother; 2017 May; 72(5):1396-1399. PubMed ID: 28088768 [TBL] [Abstract][Full Text] [Related]
18. [The etiological structure of the causative agents of inflammatory nonspecific urological diseases and the dynamics of their resistance to the widely used antibiotics]. Derevianko NI; Kotliarova GA; Kondrat'eva EM; Nefedova LA; Kudriashova EE Urol Nefrol (Mosk); 1997; (3):13-8. PubMed ID: 9245048 [TBL] [Abstract][Full Text] [Related]